Impact of iron overload on hematopoietic stem cell transplantation in pediatric patients with nonmalignant hematological disorders
Open Access
- 13 May 2026
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 10 (10) , 3324-3334
Abstract
Children with nonmalignant hematological disorders (NMHD) often require numerous red blood cell transfusions before hematopoietic stem cell transplantation (HSCT), leading to iron overload. Ferritin and liver iron concentration (LIC) are used to estimate the degree of iron overload to determine eligibility for HSCT, but neither marker has been definitively associated with poorer HSCT outcomes in pediatric cohorts. We conducted a multicenter retrospective cohort study using PEDSnet to examine the association between elevated pre-HSCT ferritin and LIC and HSCT outcomes and to evaluate iron reduction therapy after transplantation. A total of 580 patients with a pre-HSCT ferritin and 260 patients with a pre-HSCT LIC were studied. Patients with high pre-HSCT ferritin of >2500 ng/mL had decreased 3-year overall survival (adjusted hazard ratio [HR], 2.31; 95% confidence interval [CI], 1.06-5.04). A sensitivity analysis demonstrated this trend only in patients with severe aplastic anemia (SAA). Elevated ferritin was associated with a markedly increased risk of bacteremia after HSCT in patients with SAA (HR, 3.33; 95% CI, 1.72-6.44). Elevated pre-HSCT LIC of >5 mg Fe/g dry weight was not associated with decreased survival, bacteremia, graft failure, or veno-occlusive disease (VOD). VOD was assessed only in patients undergoing busulfan-based transplantation. After transplantation, 63% of patients in the multicenter analysis had an elevated ferritin, whereas 68% had an elevated LIC. Chelation and phlebotomy were equally effective in reducing post-HSCT iron. These results challenge the use of LIC as the gold standard for iron-related risk stratification in HSCT. Further research into peri-HSCT iron management is necessary in an era of expanding availability of HSCT for NMHD.Keywords
This publication has 44 references indexed in Scilit:
- Iron toxicity – Its effect on the bone marrowBlood Reviews, 2018
- Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantationBone Marrow Transplantation, 2017
- Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA studyBone Marrow Transplantation, 2016
- One‐year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantationPediatric Blood & Cancer, 2016
- Iron Overload in Allogeneic Hematopoietic Cell Transplantation Outcome: A Meta-AnalysisTransplantation and Cellular Therapy, 2014
- Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host diseaseAnnals of Hematology, 2013
- Does iron overload really matter in stem cell transplantation?American Journal of Hematology, 2012
- Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in childrenBone Marrow Transplantation, 2009
- Influence of Pretransplantation Serum Ferritin on Nonrelapse Mortality after Myeloablative and Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- The oxidative status of blood cells in a murine model of graft-versus-host diseaseAnnals of Hematology, 2007